Sector consensus Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE 21:00:02 14/08/2026 BST			5-day change	1st Jan Change
280.05 ^USD	-0.43%		+4.70%	+40.39%

08-13	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
08-10	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	281	+0.34%	14
LONZA GROUP AG	681.13	+21.07%	23
REVOLUTION MEDICINES, INC.	221.9	+8.93%	21
BEONE MEDICINES AG	433.02	+24.62%	27
IQVIA HOLDINGS INC.	275.17	+16.27%	18
CELLTRION, INC.	264,708.89	+31.7%	24
ASCENDIS PHARMA A/S	267.92	+24.83%	18
MEDPACE HOLDINGS, INC.	581.83	+0.58%	12
EUROFINS SCIENTIFIC SE	72.53	+2.96%	14
ICON PUBLIC LIMITED COMPANY	185.56	+13.74%	16
PHARMARON BEIJING CO., LTD.	38.15	-22.33%	11
BIO-TECHNE CORPORATION	70.73	-2.31%	11
ABIVAX	138.97	+35.32%	6
PRAXIS PRECISION MEDICINES, INC.	623.68	+70.03%	19
APOGEE THERAPEUTICS, INC.	134.85	+0.22%	11
PROTAGONIST THERAPEUTICS, INC.	165.31	+6.58%	13
KYMERA THERAPEUTICS, INC.	130.91	+11.52%	22
IONIS PHARMACEUTICALS, INC.	89.33	+56.07%	21
TEMPUS AI, INC.	62.64	+20.24%	14
QIAGEN N.V.	46.07	+7.26%	14
Average	13,460.48	+16.38%	16
Weighted average by Cap.	23,157.07	+17.05%	19